Subscribe To
Acceptance of Polyamine Inhibitor CAR-T Combination Abstract for Online Publication

MINNEAPOLIS, Oct. 25, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that an abstract about SBP-101 and CPP-1X (also known as DFMO or Eflornithine) research in multiple myeloma (cell lines), has been accepted for an […] The post Acceptance of Polyamine Inhibitor CAR-T Combination Abstract for Online Publication appeared first on ForexTV...
Read More
Posted: Oct 25 2023, 12:15
Author Name: forextv
Views: 042252